BCYC vs MKC · rev $1.5M vs P/E 8.4, rev $3.81B
Bicycle Therapeutics Ltd (BCYC) versus McCormick & Company Incorporated (MKC) — a side-by-side from cached financials, not a winner call.
Bicycle Therapeutics Ltd (BCYC) is a biotechnology company listed on US.
McCormick & Company Incorporated (MKC) is a packaged foods company listed on US.
Latest reported BCYC revenue for 2026-06-30 was $1.5M. Net income was -$111.2M. Revenue was up 70.9% from 2026-03-31 to 2026-06-30. BCYC currently screens at market cap $554.0M.
Latest reported MKC revenue for 2026-05-31 was $3.81B. Net income was $1.17B. MKC currently screens at market cap $13.56B and trailing P/E 8.4.
BCYC currently screens at market cap $554.0M. MKC currently screens at market cap $13.56B and trailing P/E 8.4.
Not investment advice. Open the BCYC and MKC stock pages for the full models.
Not investment advice.